Ann Marie Stewart

Ann Marie Stewart serves as a Contracting Officer for the Department of Veterans Affairs, RPO East (36C24E), where she leads the acquisition of high-complexity biomedical and laboratory services critical to advancing veteran health outcomes. She manages a specialized portfolio focused on precision medicine, genomics, metabolomics, and bioinformatics infrastructure, ensuring that cutting-edge scientific capabilities are procured in alignment with the Million Veteran Program’s strategic goals. Her acquisitions primarily support analytical laboratory operations, clinical research platforms, and data-driven diagnostic technologies, requiring deep technical understanding of laboratory instrumentation and bioanalytical workflows. Stewart maintains consistent partnerships with leading scientific and analytical service providers, including TEMPUS AI, INC, INFINITY BIOLOGIX LLC, BOOZ ALLEN HAMILTON INC, COMMONWEALTH HOME HEALTH CARE, INC., and METABOLON, INC. These relationships are characterized by long-term, performance-based contract vehicles that emphasize technical excellence, data integrity, and compliance with federal research standards. She frequently engages vendors with expertise in next-generation sequencing, mass spectrometry, and bioinformatic pipeline development, fostering collaborative procurement environments that prioritize innovation and scientific rigor. Stewart’s contracting portfolio reflects a 100% no set-aside preference, indicating a focus on full and open competition driven by technical merit rather than socioeconomic categorization. While small business participation is not formally prioritized through set-asides, her acquisitions remain accessible to all qualified vendors capable of delivering high-complexity scientific services under stringent regulatory and quality control frameworks. Her primary procurement focus lies within NAICS 334516—Analytical Laboratory Instrument Manufacturing—reflecting her specialization in procuring advanced instrumentation, automated sample processing systems, and integrated diagnostic platforms. She routinely acquires custom-configured lab equipment, software-enabled analytics tools, and turnkey laboratory solutions that support VA’s leadership in large-scale genomic and metabolomic research.